nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0334	0.0803	CcSEcCtD
Amisulpride—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0323	0.0776	CcSEcCtD
Amisulpride—HTR7—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0322	0.0551	CbGpPWpGaD
Amisulpride—HTR2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0294	0.0504	CbGpPWpGaD
Amisulpride—DRD3—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0274	0.0469	CbGpPWpGaD
Amisulpride—HTR7—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0271	0.0463	CbGpPWpGaD
Amisulpride—HTR2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0247	0.0424	CbGpPWpGaD
Amisulpride—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0247	0.0594	CcSEcCtD
Amisulpride—DRD3—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.023	0.0394	CbGpPWpGaD
Amisulpride—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.021	0.0359	CbGpPWpGaD
Amisulpride—HTR2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0206	0.0353	CbGpPWpGaD
Amisulpride—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0176	0.0302	CbGpPWpGaD
Amisulpride—HTR2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0173	0.0297	CbGpPWpGaD
Amisulpride—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0394	CcSEcCtD
Amisulpride—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0349	CcSEcCtD
Amisulpride—HTR7—GPCRs, Other—CHRM3—nephrolithiasis	0.0143	0.0245	CbGpPWpGaD
Amisulpride—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0343	CcSEcCtD
Amisulpride—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0339	CcSEcCtD
Amisulpride—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.014	0.0336	CcSEcCtD
Amisulpride—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0326	CcSEcCtD
Amisulpride—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0129	0.031	CcSEcCtD
Amisulpride—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0304	CcSEcCtD
Amisulpride—DRD3—GPCRs, Other—CHRM3—nephrolithiasis	0.0122	0.0208	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0117	0.02	CbGpPWpGaD
Amisulpride—Tension—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0255	CcSEcCtD
Amisulpride—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0252	CcSEcCtD
Amisulpride—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0104	0.025	CcSEcCtD
Amisulpride—HTR7—G alpha (s) signalling events—PTH—nephrolithiasis	0.0102	0.0175	CbGpPWpGaD
Amisulpride—HTR2B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0102	0.0174	CbGpPWpGaD
Amisulpride—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0243	CcSEcCtD
Amisulpride—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00993	0.0239	CcSEcCtD
Amisulpride—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00987	0.0237	CcSEcCtD
Amisulpride—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00967	0.0233	CcSEcCtD
Amisulpride—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00917	0.022	CcSEcCtD
Amisulpride—HTR2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00916	0.0157	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00909	0.0156	CbGpPWpGaD
Amisulpride—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00899	0.0216	CcSEcCtD
Amisulpride—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00892	0.0153	CbGpPWpGaD
Amisulpride—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00852	0.0205	CcSEcCtD
Amisulpride—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00824	0.0198	CcSEcCtD
Amisulpride—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00797	0.0192	CcSEcCtD
Amisulpride—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00784	0.0188	CcSEcCtD
Amisulpride—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00776	0.0187	CcSEcCtD
Amisulpride—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0076	0.0183	CcSEcCtD
Amisulpride—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00754	0.0181	CcSEcCtD
Amisulpride—HTR2B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00735	0.0126	CbGpPWpGaD
Amisulpride—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0173	CcSEcCtD
Amisulpride—HTR2A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00712	0.0122	CbGpPWpGaD
Amisulpride—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.007	0.0168	CcSEcCtD
Amisulpride—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00697	0.0168	CcSEcCtD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00657	0.0113	CbGpPWpGaD
Amisulpride—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0156	CcSEcCtD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00637	0.0109	CbGpPWpGaD
Amisulpride—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0152	CcSEcCtD
Amisulpride—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00624	0.015	CcSEcCtD
Amisulpride—HTR7—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00622	0.0106	CbGpPWpGaD
Amisulpride—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00603	0.0145	CcSEcCtD
Amisulpride—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00583	0.014	CcSEcCtD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00568	0.00972	CbGpPWpGaD
Amisulpride—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00561	0.0135	CcSEcCtD
Amisulpride—Headache—Hydrochlorothiazide—nephrolithiasis	0.00552	0.0133	CcSEcCtD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00533	0.00912	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00528	0.00905	CbGpPWpGaD
Amisulpride—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00524	0.0126	CcSEcCtD
Amisulpride—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00515	0.00881	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00487	0.00833	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—RGS14—nephrolithiasis	0.00469	0.00803	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0046	0.00788	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00453	0.00775	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00429	0.00734	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—RGS14—nephrolithiasis	0.00426	0.0073	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CHRM3—nephrolithiasis	0.00406	0.00694	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00404	0.00692	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—RGS14—nephrolithiasis	0.00399	0.00683	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00398	0.00681	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00389	0.00667	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—PTH—nephrolithiasis	0.00371	0.00635	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00371	0.00634	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—RGS14—nephrolithiasis	0.00362	0.0062	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00346	0.00593	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00345	0.0059	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00341	0.00584	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.00339	0.0058	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DGKH—nephrolithiasis	0.00317	0.00543	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—PTH—nephrolithiasis	0.00315	0.0054	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00305	0.00523	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.003	0.00514	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ADCY10—nephrolithiasis	0.00296	0.00507	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.0029	0.00496	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DGKH—nephrolithiasis	0.00288	0.00493	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00277	0.00475	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00273	0.00467	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00271	0.00463	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—DGKH—nephrolithiasis	0.0027	0.00461	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00264	0.00452	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00263	0.0045	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.0026	0.00444	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RGS14—nephrolithiasis	0.00252	0.00431	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADCY10—nephrolithiasis	0.00252	0.00431	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—DGKH—nephrolithiasis	0.00245	0.00419	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.00241	0.00413	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.00237	0.00406	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.0023	0.00394	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00229	0.00392	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RGS14—nephrolithiasis	0.00214	0.00366	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PTH—nephrolithiasis	0.0021	0.00359	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00209	0.00358	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CHRM3—nephrolithiasis	0.00208	0.00356	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00206	0.00353	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00203	0.00347	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00195	0.00334	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.00193	0.0033	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00192	0.00328	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PTH—nephrolithiasis	0.0019	0.00326	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.0019	0.00326	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.0019	0.00324	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.00187	0.00321	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00184	0.00315	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	0.00178	0.00305	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	0.00177	0.00303	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.00174	0.00298	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DGKH—nephrolithiasis	0.0017	0.00291	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0017	0.00291	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.00164	0.0028	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PTH—nephrolithiasis	0.00162	0.00277	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.00161	0.00276	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00155	0.00266	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.00155	0.00266	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00149	0.00255	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00147	0.00251	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DGKH—nephrolithiasis	0.00145	0.00248	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00145	0.00248	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.00136	0.00233	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00135	0.00232	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00134	0.0023	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00133	0.00228	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00124	0.00212	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	0.00123	0.0021	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.00122	0.00209	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTH—nephrolithiasis	0.00112	0.00192	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.00112	0.00192	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00111	0.00189	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.00111	0.00189	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.00109	0.00186	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00109	0.00186	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	0.00105	0.00179	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.00103	0.00176	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTH—nephrolithiasis	0.000956	0.00164	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.0008	0.00137	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000787	0.00135	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000732	0.00125	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.00072	0.00123	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SPP1—nephrolithiasis	0.000564	0.000966	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	0.000516	0.000883	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SPP1—nephrolithiasis	0.00048	0.000822	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000367	0.000629	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	0.000361	0.000619	CbGpPWpGaD
